Frequently Asked Questions

EMDrugs is a specialized resource on medications used in the emergency department, designed to support rapid clinical decision-making at the point of care.

We cover indications, dosing, cautions, and updated literature reviews.

Our objective is to provide high-quality pharmacology content tailored to Emergency Medicine. All content is written and edited by specialist emergency physicians, in collaboration with other healthcare professionals.

EMDrugs is intended for emergency physicians and trainees, clinical pharmacologists, general practitioners, physician assistants, nurse practitioners, and other professionals involved in emergency care.

EMDrugs was created in Chile 🇨🇱 in 2021 by Dr. Cristóbal Sáa, an emergency physician accredited as a specialist in Chile and certified by the Educational Commission for Foreign Medical Graduates (ECFMG, USA). He leads the project as Editor-in-Chief and writes content alongside Dr. Joaquín Chuecas, an emergency physician and clinical toxicologist.

Both are specialists in emergency medicine in Chile and currently work at Clínica Alemana de Santiago and Pontificia Universidad Católica de Chile, respectively.

EMDrugs content is primarily written by Dr. Sáa and Dr. Chuecas, with contributions and peer review from emergency physicians and medical specialists. It is supported by more than 1,400 scientific references and based on independent narrative reviews of the medical literature.

Since the launch of its first website at the inaugural FLAME Congress in Buenos Aires, Argentina, in 2024, EMDrugs has grown to reach hundreds of users worldwide.

We specialize in clinical pharmacology in Emergency Medicine, presenting medications in a practical and concise manner to support their safe and appropriate use.

Our core content includes:

  • Drug descriptions
  • Comparative tables of related medications

These are organized by pharmacological class or clinical application, focusing on medications most relevant to emergency care. Content is continuously expanding and regularly updated.

Examples include:

  • Induction agents and neuromuscular blocking agents
  • Fibrinolytic therapy
  • Vasopressors and inodilators
  • Bronchodilators
  • Anticonvulsants
  • Biological products and immunization
  • Toxicology, decontamination, and antidotes

Yes. EMDrugs focuses on pharmacology from the perspective of emergency medicine, prioritizing rapid clinical decision-making.

Our content is structured to provide:

  • Concise executive summaries

  • Clear guidance on drug use in specific clinical scenarios

We emphasize how medications should be used in practice, distinguishing between indications supported by strong evidence and those with limited or uncertain evidence.

Limitations: We focus on medications commonly used in the emergency department and do not aim to be exhaustive. EMDrugs complements other resources such as drug interaction checkers, pregnancy and lactation databases, and comprehensive drug databases.

Yes. EMDrugs provides open-access Executive Summaries for medications.

Full access includes:

  • Extended drug descriptions

  • Comparative tables with updated references

  • Customizable settings

  • Features such as personal notes and favorites

These are available through an annual subscription.

You can install EMDrugs as a web app directly from your browser—no App Store required.

How?

  1. Open EMDrugs in your preferred browser (Chrome or Safari)
  2. Tap the red INSTALL button in the menu and follow the instructions.

Notes:

  • Works like a native app for faster point-of-care access.
  • Add it to your home screen just like any other app.
  • Available on Android and iPhone (works best on Chrome and Safari).